Keywords: Multiple Sclerosis, Multiple Sclerosis, Central Vein Sign
Motivation: The central vein sign (CVS) is an emerging biomarker for distinguishing MS from other WM pathologies, reflecting perivenular inflammation typical of MS lesions.
Goal(s): This study aims to characterize the pathophysiology of CVS-positive versus CVS-negative lesions using DTI.
Approach: The analysis of four untreated RRMS patients over two months included FLAIR, T1, SWI, and DTI. Lesions were segmented on FLAIR and classified by SWI, with volumetric and DTI metrics analyzed.
Results: CVS-positive lesions were larger, showed increased gadolinium enhancement, and had higher FA values, indicating greater inflammatory activity and structural alignment, while AD and RD values were similar across both lesion types.
Impact: CVS presence in MS lesions significantly aids in distinguishing active, chronic lesions, enabling more precise monitoring of disease progression and management. This study highlights CVS’s diagnostic value, warranting routine MRI inclusion in MS protocols.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords